PA-20-070 Integrating Patient-Reported Outcomes into Routine Primary Care: Monitoring Asthma Between Visits
PA-20-070 Integrating Patient-Reported Outcomes into Routine Primary Care: Monitoring Asthma Between Visits
批准号:
10175400
负责人:
Robert Samuel Rudin
金额:
$46.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2023-04-30
中文摘要
项目摘要
COVID-19大流行给美国2500多万人带来了前所未有的风险
有哮喘的人患有慢性疾病(如哮喘)的患者更有可能出现更差的临床症状。
2019冠状病毒病呼吸系统并发症的后果。此外,与COVID-19相关的艾德就诊风险
对于哮喘更严重的患者,少数民族和低收入人群,
社会经济地位。由于慢性病的常规护理正在减少,维持药物正在减少,
未填充的哮喘患者处于甚至更大的恶化风险中。人们普遍认为,良好的哮喘
控制可以帮助预防哮喘恶化,目前的临床指南建议经常监测
哮喘控制在门诊设置,但有用的工具和实践模式,症状监测
不可用.在之前的工作中,我们开发并测试了一个简单的移动的健康(mHealth)应用程序,可以安装
使用患者报告的结果(PRO)跟踪和自我报告哮喘症状
以及诊所监测患者报告的症状作为常规的一部分的实践模式
在乎基于我们的可行性研究的成功,我们目前正在扩大和推广这种干预措施,
初级保健诊所,服务于不同的人口,包括讲西班牙语和低健康素养
患者我们正在严格评估我们的临床综合移动健康干预措施在一个
随机对照试验即将开始。在这个补充我们目前的项目,我们将使三个
增强卫生系统和医疗保健专业人员应对COVID-19的能力。
首先,我们将通过COVID-19症状筛查和相关教育来增强mHealth应用程序
材料.第二,我们将使用定量和定性方法来确定最佳做法、障碍,
在大流行期间招募患者到我们的家庭监测干预中的促进者。最后我们将
开发并验证一个预测模型,以确定哪些哮喘患者可能从我们的研究中获益最多。
使用电子健康记录(EHR)提供的数据进行干预。识别、招募和安全
监测在COVID期间可能利用急性和重症护理资源的高风险患者,
19大流行是卫生保健系统应对的关键方面。我们的工作将证明医疗保健
系统可以使用数据驱动的方法来识别具有不良结局风险的患者,
通过临床集成的数字干预,从PRO的常规和远程监测中受益。的
从这些补充目标中获得的知识将使人们更清楚地了解卫生系统如何
可能会使用健康信息技术,以保持慢性病患者的安全,如哮喘,通过改善
遵守准则。这样做不仅可以减轻COVID-19对这一人群的健康影响,
而且在未来的激增中最大限度地减少对急性和重症护理能力的压力。
英文摘要
PROJECT SUMMARY
The COVID-19 pandemic presents an unprecedented risk for the 25+ million individuals in the United States
who have asthma. Patients with chronic conditions such as asthma are more likely to have worse clinical
outcomes due the respiratory complications of COVID-19. Furthermore, the risk of COVID-19 related ED visits
and hospitalization is likely higher for patients with more severe asthma, minorities, and those of lower
socioeconomic status. As routine care of chronic disease is declining and maintenance medications are
unfilled, asthma patients are at even greater risk of exacerbations. It is widely established that good asthma
control can help prevent asthma exacerbations and current clinical guidelines recommend frequent monitoring
of asthma control in the ambulatory setting, but useful tools and practice models for symptom monitoring are
unavailable. In prior work, we developed and tested a simple mobile health (mHealth) app that can be installed
on patients' smartphones to track and self-report asthma symptoms using patient-reported outcomes (PRO)
between visits, and a practice model for clinics to monitor the patient-reported symptoms as part of routine
care. Based on the success of our feasibility study, we are currently scaling and spreading this intervention to
primary care clinics that serves a diverse population, including Spanish-speaking and low health literacy
patients. We are rigorously evaluating the effect of our clinically-integrated mHealth intervention in a
randomized controlled trial which is soon to begin. In this supplement to our current project, we will make three
enhancements to maximize health systems' and healthcare professionals' ability to respond to COVID-19.
First, we will enhancement the mHealth app with a COVID-19 symptom screener and relevant educational
materials. Second, we will use quantitative and qualitative methods to identify best practices, barriers, and
facilitators for recruiting patients to our home monitoring intervention during the pandemic. Finally, we will
develop and validate a predictive model to identify asthma patients who may benefit the most from our
intervention, using data available from the electronic health record (EHR). Identifying, recruiting, and safely
monitoring high-risk patients who could potentially utilize acute and critical care resources during the COVID-
19 pandemic are critical aspects of the healthcare system response. Our work will demonstrate how healthcare
systems can use data-driven approaches to identify patients at risk for poor outcomes who would preferentially
benefit from routine and remote monitoring of PROs via a clinically integrated digital interventions. The
knowledge gained from these supplemental aims will provide a clearer understanding of how health systems
might use health IT to keep the patients with chronic conditions, such as asthma, safe by improving
compliance with guidelines. Doing so will not only mitigate the health effects of COVID-19 in this population,
but also minimize the strain on acute and critical care capacity in future surges.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Assessing Equitable Recruitment in a Digital Health Trial for Asthma.
评估哮喘数字健康试验中的公平招募。
DOI:
10.1055/a-2090-5745
发表时间:
2023
期刊:
Applied clinical informatics
影响因子:
2.9
作者:
[Plombon,Savanna, SRudin,Robert, SulcaFlores,Jorge, Goolkasian,Gillian, Sousa,Jessica, Rodriguez,Jorge, Lipsitz,Stuart, Foer,Dinah, KDalal,Anuj]
通讯作者:
KDalal,Anuj
Toward an asthma patient-reported outcome measure for use in digital remote monitoring.
制定用于数字远程监测的哮喘患者报告的结果测量。
DOI:
10.1080/02770903.2021.1955378
发表时间:
2022
期刊:
The Journal of asthma : official journal of the Association for the Care of Asthma
影响因子:
--
作者:
[Rudin,RobertS, Qureshi,Nabeel, Foer,Dinah, Dalal,AnujK, Edelen,MariaO]
通讯作者:
Edelen,MariaO
Using mHealth and Patient-reported Outcomes to Deliver Evidence-based Asthma Care
-
批准号:9061566
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2015
-
负责人:Robert Samuel Rudin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CDC20-HDAC6-POLD1轴调控肺腺癌免疫微环境的机制研究
-
批准号:2026JJ80369
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡智
-
依托单位:
CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
-
批准号:2026JJ50313
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡希恒
-
依托单位:
USP20调控泛素化修饰介导微卫星稳定型结直肠癌免疫逃逸的机制研究
-
批准号:JCZRLH202600106
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
巴多昔芬通过重编程肿瘤相关巨噬细胞抑制CCL20介导的Treg募集并增敏乳腺癌免疫治疗的机制研究
-
批准号:JCZRQNB202600315
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IFT20 抑制肝星状细胞活化并诱导其凋亡的机制研究
-
批准号:2026JJ82074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:金富昌
-
依托单位:
新型可降解聚酯P20-2C联合利福平根除关节假体表面细菌生物膜的机制与应用研究
-
批准号:2026JJ82609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱怡
-
依托单位:
CL-20共晶/Al纳米复合炸药热分解-燃烧反应机理研究
-
批准号:JCZRLH202601722
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
SFRT激活新型STING调控因子协同CD3/CD20双抗治疗RR DLBCL的机制研究
-
批准号:JCZRLH202600672
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
亚20nm FinFET工艺下SRAM单粒子翻转机制及抗辐照加固关键技术研究
-
批准号:2026JJ60232
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:喻国芳
-
依托单位:
合肥长安燃油泵及支架总成1106100-DS20的研发及应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:冯国雄
-
依托单位: